Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 517

1.

Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells.

Kapadia CH, Ioele SA, Day ES.

J Biomed Mater Res A. 2019 Nov 19. doi: 10.1002/jbm.a.36840. [Epub ahead of print]

PMID:
31742868
2.

Bladder reinnervation by somatic nerve transfer to pelvic nerve vesical branches does not reinnervate the urethra.

Barbe MF, Braverman AS, Salvadeo DM, Gomez-Amaya SM, Lamarre NS, Brown JM, De EJ, McIntyre BS, Day EP, Cruz GE, Frara N, Ruggieri MR Sr.

Neurourol Urodyn. 2019 Nov 13. doi: 10.1002/nau.24217. [Epub ahead of print]

PMID:
31724210
3.

Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.

Dasgupta A, Tinch S, Szczur K, Ernst R, Shryock N, Kaylor C, Lewis K, Day E, Truong T, Swaney W.

Methods Mol Biol. 2020;2086:27-60. doi: 10.1007/978-1-0716-0146-4_3.

PMID:
31707666
4.

Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer.

Valcourt DM, Dang MN, Wang J, Day ES.

Ann Biomed Eng. 2019 Nov 4. doi: 10.1007/s10439-019-02399-7. [Epub ahead of print]

PMID:
31686312
5.

Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.

Bloch E, Sikorski EL, Pontoriero D, Day EK, Berger BW, Lazzara MJ, Thévenin D.

J Biol Chem. 2019 Nov 1. pii: jbc.RA119.010229. doi: 10.1074/jbc.RA119.010229. [Epub ahead of print]

6.

Increased toe-flexor muscle strength does not alter metatarsophalangeal and ankle joint mechanics or running economy.

Day EM, Hahn ME.

J Sports Sci. 2019 Dec;37(23):2702-2710. doi: 10.1080/02640414.2019.1661562. Epub 2019 Sep 5.

PMID:
31608832
7.

Comparing glycaemic benefits of active versus passive lifestyle intervention in kidney allograft recipients (CAVIAR): a randomised controlled trial.

Kuningas K, Driscoll J, Mair R, Smith H, Dutton M, Day E, Sharif A.

Transplantation. 2019 Sep 18. doi: 10.1097/TP.0000000000002969. [Epub ahead of print]

PMID:
31568390
8.

A view from the acute hospital: managing patients with alcohol problems.

Pang D, Duffield P, Day E.

Br J Hosp Med (Lond). 2019 Sep 2;80(9):500-506. doi: 10.12968/hmed.2019.80.9.500.

PMID:
31498680
9.

Acute Effects of Wedge Orthoses and Sex on Iliotibial Band Strain During Overground Running in Nonfatiguing Conditions.

Day EM, Gillette JC.

J Orthop Sports Phys Ther. 2019 Oct;49(10):743-750. doi: 10.2519/jospt.2019.8837. Epub 2019 Aug 31.

PMID:
31475615
10.

The utility of intraoperative MRI during pediatric brain tumor surgery: a single-surgeon case series.

Day EL, Scott RM.

J Neurosurg Pediatr. 2019 Aug 23:1-7. doi: 10.3171/2019.6.PEDS1998. [Epub ahead of print]

PMID:
31443079
11.

Dynamic angular stiffness about the metatarsophalangeal joint increases with running speed.

Day EM, Hahn ME.

Hum Mov Sci. 2019 Oct;67:102501. doi: 10.1016/j.humov.2019.102501. Epub 2019 Jul 22.

PMID:
31344545
12.

Alcohol use disorders and the heart.

Day E, Rudd JHF.

Addiction. 2019 Sep;114(9):1670-1678. doi: 10.1111/add.14703. Epub 2019 Jul 15.

13.

GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury.

Platko K, Lebeau PF, Byun JH, Poon SV, Day EA, MacDonald ME, Holzapfel N, Mejia-Benitez A, Maclean KN, Krepinsky JC, Austin RC.

Mol Metab. 2019 Sep;27:62-74. doi: 10.1016/j.molmet.2019.06.021. Epub 2019 Jun 28.

14.
15.

Revisiting theory on research use: Turning to policymakers for fresh insights.

Bogenschneider K, Day E, Parrott E.

Am Psychol. 2019 Oct;74(7):778-793. doi: 10.1037/amp0000460. Epub 2019 May 2.

PMID:
31045380
16.

Blocking CCN2 Reduces Progression of Sensorimotor Declines and Fibrosis in a Rat Model of Chronic Repetitive Overuse.

Barbe MF, Hilliard BA, Delany SP, Iannarone VJ, Harris MY, Amin M, Cruz GE, Barreto-Cruz Y, Tran N, Day EP, Hobson LJ, Assari S, Popoff SN.

J Orthop Res. 2019 Sep;37(9):2004-2018. doi: 10.1002/jor.24337. Epub 2019 Jun 20.

17.

IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.

Valcourt DM, Dang MN, Day ES.

J Biomed Mater Res A. 2019 Aug;107(8):1702-1712. doi: 10.1002/jbm.a.36685. Epub 2019 Apr 9.

PMID:
30920169
18.

Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis.

Garson JA, Usher L, Al-Chalabi A, Huggett J, Day EF, McCormick AL.

Acta Neuropathol Commun. 2019 Mar 18;7(1):45. doi: 10.1186/s40478-019-0698-2.

19.

Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.

Day E, Broder T, Bruneau J, Cruse S, Dickie M, Fish S, Grillon C, Luhmann N, Mason K, McLean E, Trooskin S, Treloar C, Grebely J.

Int J Drug Policy. 2019 Apr;66:87-93. doi: 10.1016/j.drugpo.2019.01.012. Epub 2019 Feb 8.

PMID:
30743093
20.

A comparison of metatarsophalangeal joint center locations on estimated joint moments during running.

Day EM, Hahn ME.

J Biomech. 2019 Mar 27;86:64-70. doi: 10.1016/j.jbiomech.2019.01.044. Epub 2019 Jan 30.

PMID:
30738588
21.

Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT.

Strang J, Kelleher M, Mayet S, Day E, Hellier J, Byford S, Murphy C, McLennan B, Shearer J, Ryan E, Marsden J.

Health Technol Assess. 2019 Jan;23(3):1-72. doi: 10.3310/hta23030.

22.

Do medical students studying in the United Kingdom have an adequate factual knowledge of basic life support?

Willmore RD, Veljanoski D, Ozdes F, Stephens B, Mooney J, Crumley SG, Doshi A, Davies P, Badhrinarayanan S, Day E, Tattam K, Wilson A, Crang N, Green L, Mounsey CA, Fu H, Williams J, D'souza MS, Sebastian D, Mcgiveron LA, Percy MG, Cohen J, John IJ, Lethbridge A, Watkins I, Amin O, Qamar MA, Hanrahan JG, Cramond-Wong E.

World J Emerg Med. 2019;10(2):75-80. doi: 10.5847/wjem.j.1920-8642.2019.02.002.

23.

Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a.

Goyal R, Kapadia CH, Melamed JR, Riley RS, Day ES.

Cell Mol Bioeng. 2018 Oct;11(5):383-396. doi: 10.1007/s12195-018-0535-x. Epub 2018 Jun 6.

24.

Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer.

Wu P, Sneeringer CJ, Pitts KE, Day ES, Chan BK, Wei B, Lehoux I, Mortara K, Li H, Wu J, Franke Y, Moffat JG, Grogan JL, Heffron TP, Wang W.

Structure. 2019 Jan 2;27(1):125-133.e4. doi: 10.1016/j.str.2018.10.025. Epub 2018 Nov 29.

PMID:
30503777
25.

Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.

Melamed JR, Ioele SA, Hannum AJ, Ullman VM, Day ES.

Mol Pharm. 2018 Nov 5;15(11):5135-5145. doi: 10.1021/acs.molpharmaceut.8b00707. Epub 2018 Oct 11.

26.

Parental Knowledge Discrepancies: Examining the Roles of Warmth and Self-Disclosure.

Dotterer AM, Day E.

J Youth Adolesc. 2019 Mar;48(3):459-468. doi: 10.1007/s10964-018-0926-2. Epub 2018 Sep 15.

PMID:
30218344
27.

Spherical Nucleic Acid Architecture Can Improve the Efficacy of Polycation-Mediated siRNA Delivery.

Melamed JR, Kreuzberger NL, Goyal R, Day ES.

Mol Ther Nucleic Acids. 2018 Sep 7;12:207-219. doi: 10.1016/j.omtn.2018.05.008. Epub 2018 Jun 2.

28.

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.

Day E, Hellard M, Treloar C, Bruneau J, Martin NK, Øvrehus A, Dalgard O, Lloyd A, Dillon J, Hickman M, Byrne J, Litwin A, Maticic M, Bruggmann P, Midgard H, Norton B, Trooskin S, Lazarus JV, Grebely J; International Network on Hepatitis in Substance Users (INHSU).

Liver Int. 2019 Jan;39(1):20-30. doi: 10.1111/liv.13949. Epub 2018 Sep 22. Review.

PMID:
30157316
29.

Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells.

Riley RS, O'Sullivan RK, Potocny AM, Rosenthal J, Day ES.

Nanomaterials (Basel). 2018 Aug 25;8(9). pii: E658. doi: 10.3390/nano8090658.

30.

Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial.

Anderson BM, Dutton M, Day E, Jackson TA, Ferro CJ, Sharif A.

Trials. 2018 Aug 24;19(1):457. doi: 10.1186/s13063-018-2842-x.

31.

Photochemotherapeutic Properties of a Linear Tetrapyrrole Palladium(II) Complex displaying an Exceptionally High Phototoxicity Index.

Potocny AM, Riley RS, O'Sullivan RK, Day ES, Rosenthal J.

Inorg Chem. 2018 Sep 4;57(17):10608-10615. doi: 10.1021/acs.inorgchem.8b01225. Epub 2018 Aug 22.

32.

Enzyme-Linked Immunosorbent Assay to Quantify Targeting Molecules on Nanoparticles.

Riley RS, Melamed JR, Day ES.

Methods Mol Biol. 2018;1831:145-157. doi: 10.1007/978-1-4939-8661-3_11.

PMID:
30051430
33.

Out-of-hospital arrests attending an Australian tertiary paediatric emergency department over 13 years: An observational study.

Day E, Hort JR.

Emerg Med Australas. 2018 Oct;30(5):687-693. doi: 10.1111/1742-6723.13127. Epub 2018 Jul 18.

PMID:
30021244
34.

Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.

Kapadia CH, Melamed JR, Day ES.

BioDrugs. 2018 Aug;32(4):297-309. doi: 10.1007/s40259-018-0290-5. Review.

35.

Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide.

Melamed JR, Morgan JT, Ioele SA, Gleghorn JP, Sims-Mourtada J, Day ES.

Oncotarget. 2018 Jun 5;9(43):27000-27015. doi: 10.18632/oncotarget.25467. eCollection 2018 Jun 5.

36.

Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.

Metrebian N, Weaver T, Pilling S, Hellier J, Byford S, Shearer J, Mitcheson L, Astbury M, Bijral P, Bogdan N, Bowden-Jones O, Day E, Dunn J, Finch E, Forshall S, Glasper A, Morse G, Akhtar S, Bajaria J, Bennett C, Bishop E, Charles V, Davey C, Desai R, Goodfellow C, Haque F, Little N, McKechnie H, Morris J, Mosler F, Mutz J, Pauli R, Poovendran D, Slater E, Strang J.

Contemp Clin Trials. 2018 Aug;71:124-132. doi: 10.1016/j.cct.2018.06.008. Epub 2018 Jun 13.

PMID:
29908336
37.

Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP.

Peak J, Goranitis I, Day E, Copello A, Freemantle N, Frew E.

Health Qual Life Outcomes. 2018 May 30;16(1):106. doi: 10.1186/s12955-018-0926-7.

38.

Here's the NEWS from Belgium….

Haig S, Day EA.

Resuscitation. 2018 Aug;129:A9-A10. doi: 10.1016/j.resuscitation.2018.05.019. Epub 2018 May 24. No abstract available.

PMID:
29803704
39.

Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation.

Riley RS, Dang MN, Billingsley MM, Abraham B, Gundlach L, Day ES.

Nano Lett. 2018 Jun 13;18(6):3565-3570. doi: 10.1021/acs.nanolett.8b00681. Epub 2018 May 2.

40.

Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models.

Esquejo RM, Salatto CT, Delmore J, Albuquerque B, Reyes A, Shi Y, Moccia R, Cokorinos E, Peloquin M, Monetti M, Barricklow J, Bollinger E, Smith BK, Day EA, Nguyen C, Geoghegan KF, Kreeger JM, Opsahl A, Ward J, Kalgutkar AS, Tess D, Butler L, Shirai N, Osborne TF, Steinberg GR, Birnbaum MJ, Cameron KO, Miller RA.

EBioMedicine. 2018 May;31:122-132. doi: 10.1016/j.ebiom.2018.04.009. Epub 2018 Apr 8.

41.

Parental Involvement and Adolescent Academic Outcomes: Exploring Differences in Beneficial Strategies across Racial/Ethnic Groups.

Day E, Dotterer AM.

J Youth Adolesc. 2018 Jun;47(6):1332-1349. doi: 10.1007/s10964-018-0853-2. Epub 2018 Apr 18.

PMID:
29671243
42.

Compositional heterogeneity near the base of the mantle transition zone beneath Hawaii.

Yu C, Day EA, de Hoop MV, Campillo M, Goes S, Blythe RA, van der Hilst RD.

Nat Commun. 2018 Mar 28;9(1):1266. doi: 10.1038/s41467-018-03654-6.

44.

A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.

Day E, Copello A, Seddon JL, Christie M, Bamber D, Powell C, Bennett C, Akhtar S, George S, Ball A, Frew E, Goranitis I, Freemantle N.

BMC Psychiatry. 2018 Jan 15;18(1):8. doi: 10.1186/s12888-018-1600-7.

45.

Commentary on Jones et al. (2018): An inconvenient truth-complex problems require complex solutions.

Day E.

Addiction. 2018 Feb;113(2):287-288. doi: 10.1111/add.14070. No abstract available.

PMID:
29314403
46.

Malignant tumours arising within mature cystic teratomas of the ovary: Prevalence and clinical outcomes.

Duffy S, Day EK, Bryson G, Millan D, Lindsay R.

Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:198-199. doi: 10.1016/j.ejogrb.2017.12.022. Epub 2017 Dec 21. Review. No abstract available.

PMID:
29289502
47.

"We just follow the patients' lead": Healthcare professional perspectives on the involvement of teenagers with cancer in decision making.

Day E, Jones L, Langner R, Stirling LC, Hough R, Bluebond-Langner M.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26898. Epub 2017 Dec 8.

PMID:
29218835
48.

Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy.

Bogdanowicz KM, Stewart R, Chang CK, Shetty H, Khondoker M, Day E, Hayes RD, Strang J.

Addiction. 2018 May;113(5):946-951. doi: 10.1111/add.14114. Epub 2018 Jan 10.

PMID:
29179255
49.

Integrating acute stroke telemedicine consultations into specialists' usual practice: a qualitative analysis comparing the experience of Australia and the United Kingdom.

Bagot KL, Cadilhac DA, Bladin CF, Watkins CL, Vu M, Donnan GA, Dewey HM, Emsley HCA, Davies DP, Day E, Ford GA, Price CI, May CR, McLoughlin ASR, Gibson JME, Lightbody CE; VST and ASTUTE investigators.

BMC Health Serv Res. 2017 Nov 21;17(1):751. doi: 10.1186/s12913-017-2694-1.

50.

Does the Addition of a "Black Bone" Sequence to a Fast Multisequence Trauma MR Protocol Allow MRI to Replace CT after Traumatic Brain Injury in Children?

Dremmen MHG, Wagner MW, Bosemani T, Tekes A, Agostino D, Day E, Soares BP, Huisman TAGM.

AJNR Am J Neuroradiol. 2017 Nov;38(11):2187-2192. doi: 10.3174/ajnr.A5405. Epub 2017 Sep 28.

Supplemental Content

Support Center